EXPLORE OUR RESOURCES
oNKo-innate
Learning Centre
What will you discover today?
Featured Articles
Topics
All News
-
Firing Up the Cold Tumor: A Major Obstacle in Cancer Therapy
Read more: Firing Up the Cold Tumor: A Major Obstacle in Cancer Therapy -
An Introduction to Cytokine Therapy: Your Questions Answered
Read more: An Introduction to Cytokine Therapy: Your Questions Answered -
–
Iva Nikolic promoted to Chief Technology Officer
Read more: Iva Nikolic promoted to Chief Technology Officer -
–
oNKo-innate named Australian Emerging Company of the Year 2021
Read more: oNKo-innate named Australian Emerging Company of the Year 2021 -
The cancer–natural killer cell immunity cycle
Read more: The cancer–natural killer cell immunity cycle -
–
Monash University and oNKo-innate Announce Research Partnership
Read more: Monash University and oNKo-innate Announce Research Partnership -
–
Onko-Innate, Gilead, Kite Work On NK Cancer Immunotherapies
Read more: Onko-Innate, Gilead, Kite Work On NK Cancer Immunotherapies -
–
Immunotherapy biotech scores Gilead partnership
Read more: Immunotherapy biotech scores Gilead partnership -
–
Interest builds in next-generation cancer immunotherapies
Read more: Interest builds in next-generation cancer immunotherapies -
–
Gilead, oNKo-innate to develop NK cells-focused cancer immunotherapies
Read more: Gilead, oNKo-innate to develop NK cells-focused cancer immunotherapies -
–
Gilead, Kite pen natural killer pact with little-known Australian cell therapy player
Read more: Gilead, Kite pen natural killer pact with little-known Australian cell therapy player